Electrochemical Skin Conductance as a Marker of Painful Oxaliplatin-Induced Peripheral Neuropathy
Purpose. Oxaliplatin is a platinum compound widely used in gastrointestinal cancer treatment but produces dose-limiting peripheral neuropathy. New insights into oxaliplatin-induced peripheral neuropathy (OIPN) assessment are needed to detect more effectively this condition. In this context, we condu...
Saved in:
Main Authors: | Jean-Baptiste Delmotte, Abdulkarim Tutakhail, Kahina Abdallah, Pauline Reach, Marguerite D’Ussel, Gael Deplanque, Hélène Beaussier, François Coudoré |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Neurology Research International |
Online Access: | http://dx.doi.org/10.1155/2018/1254602 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Electrochemical skin conductance to assess peripheral neuropathy in rheumatic diseases with or without type 2 diabetes using sudoscan
by: Osama M. I. Mohamed, et al.
Published: (2025-01-01) -
Reestablishment of Redox Homeostasis in the Nociceptive Primary Afferent as a Mechanism of Antinociception Promoted by Mesenchymal Stem/Stromal Cells in Oxaliplatin-Induced Chronic Peripheral Neuropathy
by: Anna Lethicia L. Oliveira, et al.
Published: (2021-01-01) -
Progress on spinal cord stimulation in treatment of peripheral neuropathy
by: ZONG Yun⁃fei, et al.
Published: (2025-01-01) -
Peripheral neuropathy as initial manifestation of Churg-Strauss Syndrome
by: Antonio Villa, et al.
Published: (2020-03-01) -
Electrochemical Skin Conductance May Be Used to Screen for Diabetic Cardiac Autonomic Neuropathy in a Chinese Population with Diabetes
by: Tianyi He, et al.
Published: (2017-01-01)